Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Hu

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|October 10, 2014
Genetic analysis should be included in clinical practice when screening for antithrombin deficiencyWei Zeng, Liang Tang, Xiao-Rong Jian, et al.
Leukemia & Lymphoma|August 10, 2017
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphomaBei Hu, Anas Younes, Jason R Westin, et al.
Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.
Acta Pharmacologica Sinica|August 29, 2020
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphomaXiao-Tuan Zhang, Xiao-Bei Hu, Han-Lin Wang, et al.
Nature Materials|August 27, 2025
High-quality narrow black phosphorus nanoribbons with nearly atomically smooth edges and well-defined edge orientationTeng Zhang, Youxin Chen, Zhiyan He, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
Transplantation and Cellular Therapy|September 13, 2024
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell LymphomaBei Hu, Rakhee Vaidya, Ferdous Ahmed, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Acta Pharmacologica Sinica|March 30, 2021
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignanciesKai-Long Jiang, Le-Xian Tong, Tao Wang, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|October 10, 2014
Genetic analysis should be included in clinical practice when screening for antithrombin deficiencyWei Zeng, Liang Tang, Xiao-Rong Jian, et al.
Leukemia & Lymphoma|August 10, 2017
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphomaBei Hu, Anas Younes, Jason R Westin, et al.
Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.
Acta Pharmacologica Sinica|August 29, 2020
Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphomaXiao-Tuan Zhang, Xiao-Bei Hu, Han-Lin Wang, et al.
Nature Materials|August 27, 2025
High-quality narrow black phosphorus nanoribbons with nearly atomically smooth edges and well-defined edge orientationTeng Zhang, Youxin Chen, Zhiyan He, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
Transplantation and Cellular Therapy|September 13, 2024
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell LymphomaBei Hu, Rakhee Vaidya, Ferdous Ahmed, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Blood Advances|September 8, 2023
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA studyStephen Opat, Alessandra Tedeschi, Bei Hu, et al.
Acta Pharmacologica Sinica|March 30, 2021
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignanciesKai-Long Jiang, Le-Xian Tong, Tao Wang, et al.
Pageof 22